News
Q1 2025 Results Conference Call May 7, 2025 2:30 AM ETCompany ParticipantsKarl Hersvik - Chief Executive OfficerDavid Tønne ...
Q1 2025 Earnings Call Transcript May 8, 2025 Iovance Biotherapeutics, Inc. misses on earnings expectations. Reported EPS is $ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback